[Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
Doffoël
M
M
Vetter
D
D
D000208:Acute Disease; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage / Q000150:complications*; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008353:Mannitol / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use*; D007507:Therapeutic Irrigation
D008353:Mannitol; D007792:Lactulose; D009355:Neomycin
Le traitement "spécifique" de l'encéphalopathie hépatique aiguë est-il justifié au cours de la cirrhose?